SCOPE FLUIDICS SA ZY-10 Total Liabilities
SCOPE FLUIDICS SA ZY-10 total liabilities. Based on the latest financial reports, SCOPE FLUIDICS SA ZY-10 (S84) has total liabilities worth €33.50 Million EUR (≈ $39.17 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See defensive interval ratio of SCOPE FLUIDICS SA ZY-10 to measure how many days the company can operate on defensive assets alone.
Total Liabilities of SCOPE FLUIDICS SA ZY-10 (2021–2025)
Total liabilities of SCOPE FLUIDICS SA ZY-10 from 2021 to 2025. This chart illustrates how SCOPE FLUIDICS SA ZY-10's total liabilities have evolved over time, based on quarterly financial data. Check S84 financial resilience to evaluate the company's liquid asset resilience ratio.
SCOPE FLUIDICS SA ZY-10 Competitors by Total Liabilities
The table below lists competitors of SCOPE FLUIDICS SA ZY-10 ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Oil Terminal C
RO:OIL
|
Romania | RON319.26 Million |
|
Kandi Technologies Group Inc
NASDAQ:KNDI
|
USA | $87.39 Million |
|
ANDRADA MINING LTD.
F:9IA
|
Germany | €43.56 Million |
|
China New Higher Education Group Limited
F:8CN
|
Germany | €5.63 Billion |
|
Peel Mining Ltd
AU:PEX
|
Australia | AU$1.76 Million |
|
Nasmedia Co. Ltd
KQ:089600
|
Korea | ₩185.10 Billion |
|
Actinogen Medical Ltd
AU:ACW
|
Australia | AU$6.15 Million |
|
Themis Medicare Limited
NSE:THEMISMED
|
India | Rs-3.99 Billion |
Liability Composition Analysis (2021–2025)
This chart breaks down SCOPE FLUIDICS SA ZY-10's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see S84 current and non-current assets.
Liquidity & Leverage Metrics
SCOPE FLUIDICS SA ZY-10 Total Liabilities Ratios Explained
SCOPE FLUIDICS SA ZY-10 total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 13.06 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.21 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.17 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how SCOPE FLUIDICS SA ZY-10's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for SCOPE FLUIDICS SA ZY-10 (2021–2025)
The table below shows the annual total liabilities of SCOPE FLUIDICS SA ZY-10 from 2021 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €33.50 Million ≈ $39.17 Million |
+26.34% |
| 2024-12-31 | €26.52 Million ≈ $31.00 Million |
+28.99% |
| 2023-12-31 | €20.56 Million ≈ $24.04 Million |
+55.96% |
| 2022-12-31 | €13.18 Million ≈ $15.41 Million |
-71.34% |
| 2021-12-31 | €45.99 Million ≈ $53.77 Million |
-- |
About SCOPE FLUIDICS SA ZY-10
Scope Fluidics S.A., a biotechnology company, designs and develops projects based on microfluidic technologies in medical diagnostics and healthcare in Poland. The company offers BacterOMIC, an antibiotic susceptibility testing. Scope Fluidics S.A. was founded in 2010 and is based in Warsaw, Poland.